Inspire Medical Systems (NYSE:INSP) shares took a hit today despite fourth-quarter results that beat the consensus forecast. Shares of INSP fell nearly 7% at $210.35 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — stayed even. The Minneapolis-based maker of neuromodulation implants for […]
Inspire Medical Systems Inc.
Inspire Medical CEO takes over as board chair
Inspire Medical Systems (NYSE:INSP) announced today that Marilyn Carlson Nelson retired as chair of the company’s board of directors. The Minneapolis-based sleep apnea treatment developer appointed current CEO Timothy Herbert to the additional role of board chair. Herbert’s appointment goes into effect after the company’s annual meeting of stockholders on May 2, 2024. Nelson became […]
Longtime Inspire Medical board member Dr. Jerry Griffin to retire
Inspire Medical Systems (NYSE:INSP) announced today that Dr. Jerry C. Griffin intends to retire from its board of directors. Griffin plans to retire at the conclusion of the company’s annual meeting of stockholders on May 2, 2024. The longtime director joined the Inspire board in 2008 as one of the original board members. He joined […]
Inspire Medical adds Intuitive CMO Dr. Myriam Curet to its board
Inspire Medical Systems (NYSE:INSP) announced today that it appointed Dr. Myriam J. Curet as an independent board director. Curet’s appointment went into effect on Dec. 21, 2023. She currently serves as EVP and chief medical officer at surgical robotics pioneer Intuitive Surgical. Curet spoke to Medical Design & Outsourcing this year to explain the secret behind […]
Investors file class action against Inspire Medical, allege misleading statements
Two law firms in New York announced the filing of a class action lawsuit by investors against Inspire Medical Systems (NYSE:INSP). Bragar Eagel & Squire, P.C., and Bernstein Liebhard LLP filed on behalf of persons or entities who purchased or otherwise acquired Inspire Medical common stock between May 3, 2023, and Nov. 7, 2023. The […]
Inspire Medical Systems revenue misses in Q3
Inspire Medical Systems (NYSE: INSP) reported third-quarter revenue that missed the Wall Street analysts consensus. However, the Minneapolis-based implantable sleep therapy device company also upped its full-year guidance. Investors appeared to focus on the downside after Inspire’s Q3 earnings report yesterday evening. By midday trading today, INSP shares were down more than 16% to $134.90 […]
Inspire Medical stock rises after hours on Q2 beats, increased guidance
Inspire Medical Systems (NYSE:INSP) shares ticked up after hours today on second-quarter results that beat the consensus forecast. Shares of INSP rose 1.4% at $295 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.5%. The Minneapolis-based implantable […]
Inspire Medical appoints former AppliedVR exec as chief medical officer
Inspire Medical Systems announced today that it named Dr. Charisse Sparks as its new chief medical officer (CMO). Minneapolis-based Inspire made Sparks’ appointment effective on July 27. As CMO, she serves as a member of the sleep apnea treatment maker’s executive leadership teams. Sparks’ responsibilities include leading medical and clinical affairs, reporting to President and […]
Inspire Medical Systems picks former Medtronic exec as new chief strategy officer
Inspire Medical Systems (NYSE: INSP) today announced the appointment of Carlton Weatherby as its chief strategy officer (CSO). Weatherby’s appointment goes into effect today, July 24, 2023. He joins Inspire from Medtronic, most recently serving as VP and GM of the medtech giant’s Spine & Biologics business. Weatherby took on that role in 2021, previously […]
Inspire Medical wins expanded FDA approval for sleep apnea therapy
Inspire Medical Systems (NYSE:INSP) announced today that the FDA approved an expanded indication for its sleep apnea therapy. Minneapolis-based Inspire develops minimally invasive solutions for patients with obstructive sleep apnea (OSA). The proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that treats moderate to severe OSA. It offers an alternative to traditional […]
Inspire Medical grows sales 84% in Q1, raises full-year guidance
Inspire Medical Systems (NYSE:INSP) this week posted first-quarter results that beat the overall consensus on Wall Street. The Minneapolis-based implantable sleep therapy device company reported profit losses of $15.4 million, or 53¢ per share, on sales of $127.9 million for the three months ended March 31, for a sales growth of 84.34% compared to Q1 […]